To access this element change to forms mode OFF
Grant Award View - GA166535
A single dose, globally accessible vaccine to combat emerging SARS-CoV-2...
GA ID:
GA166535
Agency:
Department of Health and Aged Care
Approval Date:
12-Feb-2021
Publish Date:
25-May-2021
Category:
Health and Medical Research
Grant Term:
1-Mar-2021 to 28-Feb-2023
Value (AUD):
$1,556,560.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_COVID-19_Vaccine_Candidate_Research_R2
Grant Activity:
A single dose, globally accessible vaccine to combat emerging SARS-CoV-2 variants
Purpose:
The emergence of highly transmissible SARS-CoV-2 variants threatens to derail COVID-19 control efforts. We have developed a next-generation vaccine, delivered as a single dose, that targets these variants. In this proposal we willl undertake late-stage pre-clinical testing to determine the optimal vaccine formulation, define protective efficacy against SARS-CoV-2 infection and assess vaccine safety/tolerability. Outcomes will be used to fast track vaccine progression to clinical testing.
GO ID:
GO Title:
MRFF – 2020 COVID-19 Vaccine Candidate Research grant opportunity
Internal Reference ID:
MRF2007221
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA